Learn More
Medchemexpress LLC CHMFL-PI4K-127 | 2377604-81-2 | C18H15ClN4O3S | 100 MG

Supplier: Medchemexpress LLC HY150598100MG
CHMFL-PI4K-127 (compound 15g) is an orally active, potent, and highly selective PfPI4K (Plasmodium falciparum PI4K kinase) inhibitor with an IC50 of 0.9 nM. It demonstrates potent activity against 3D7 Plasmodium falciparum, exhibiting an EC50 of 25.1 nM. This compound shows antimalaria efficacy, displaying high selectivity against PfPI4K over human lipid and protein kinases. In vivo studies in rodent models demonstrated significant antimalarial activities in a dose-dependent manner, generating curative effects in the blood stage at 80 mg/kg and full protection in the liver stage at 1 mg/kg.
- Potent and highly selective PfPI4K inhibitor
- Orally active
- Shows antimalaria efficacy
- High selectivity against PfPI4K over human lipid and protein kinases
- Significant antimalarial activities in rodent models
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.